Appraisal of evidence and control of bias in the kidney disease outcomes quality initiative guideline development process.

Appraisal of Evidence and Control of Bias in the Kidney Disease Outcomes Quality Initiative Guideline Development Process David Van Wyck,* Kai-Uwe Eckardt, Katrin Uhlig, Michael Rocco, and Adeera Levin *Department of Medicine, University of Arizona College of Medicine, Tucson, Arizona; Department of Nephrology and Hypertension, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina; and Department of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada Clin J Am Soc Nephrol 2: 8–10, 2007. doi: 10.2215/CJN.02840806